nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock
|
Tehrani, Behnam N. |
|
|
8 |
11 |
p. 879-891 |
artikel |
2 |
Can a Pulmonary Artery Catheter Improve Outcomes in Cardiogenic Shock? ∗
|
Fang, James C. |
|
|
8 |
11 |
p. 914-916 |
artikel |
3 |
Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality
|
Garan, A. Reshad |
|
|
8 |
11 |
p. 903-913 |
artikel |
4 |
Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction
|
Leggio, Massimo |
|
|
8 |
11 |
p. 956 |
artikel |
5 |
Heart Transplantation Allocation Under New Policy
|
Trivedi, Jaimin R. |
|
|
8 |
11 |
p. 957-958 |
artikel |
6 |
Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support
|
Chung, Mabel |
|
|
8 |
11 |
p. 892-902 |
artikel |
7 |
In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States
|
Greene, Stephen J. |
|
|
8 |
11 |
p. 943-953 |
artikel |
8 |
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
|
Ezekowitz, Justin A. |
|
|
8 |
11 |
p. 931-939 |
artikel |
9 |
Personalized Therapeutic Approach
|
O’Connor, Christopher M. |
|
|
8 |
11 |
p. 954-955 |
artikel |
10 |
Reply
|
Jawitz, Oliver K. |
|
|
8 |
11 |
p. 958-959 |
artikel |
11 |
Reply
|
Koepp, Katlyn E. |
|
|
8 |
11 |
p. 957 |
artikel |
12 |
Should the LIFE Trial Assess Improvement in Ejection Fraction as a Primary Endpoint?
|
Ioannou, Adam |
|
|
8 |
11 |
p. 959-960 |
artikel |
13 |
Socioeconomic Gradients in Mortality Following HF Hospitalization in a Country With Universal Health Care Coverage
|
Sulo, Gerhard |
|
|
8 |
11 |
p. 917-927 |
artikel |
14 |
Vericiguat in Heart Failure With Reduced Ejection Fraction With High Natriuretic Peptides
|
Cunningham, Jonathan W. |
|
|
8 |
11 |
p. 940-942 |
artikel |
15 |
What Can We Learn From Norway?
|
Allen, Larry A. |
|
|
8 |
11 |
p. 928-930 |
artikel |